Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial

NCT: NCT03706833 · ACTIVE_NOT_RECRUITING

NCT IDNCT03706833
StatusACTIVE_NOT_RECRUITING
Start Date2018-11-30
Completion2031-06-30

Brief Summary

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by the Heart Team, and in patients with functional mitral regurgitation (FMR) on guideline directed medical therapy (GDMT)

Frequently Asked Questions

What is Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial?

Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial is a clinical trial registered under NCT03706833. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03706833?

The current status of NCT03706833 (Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial) is: ACTIVE_NOT_RECRUITING.

When did Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial start?

Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial started on 2018-11-30.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑